CIK 0001622229 · Large accelerated filer
Cogent Biosciences, Inc.
Sign in to watch- Ticker
- COGT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465308248
- Phone
- 617-945-5576
- Business address
- 180 THIRD AVENUE, 4TH FLOOR, WALTHAM, MA
- Former names
- Unum Therapeutics Inc., Unum Therapeutics, Inc.
- 8-K Event Executive or director change · Regulation FD disclosure
- 8-K Event Executive or director change
- EFFECT Other Notice of Effectiveness
- 4 Insider Changes in Ownership
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- DEFM14A Deal DEFM14A
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- 10-Q/A Report 10-Q/A
- UPLOAD Other SEC-generated Letter
- 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
- 4 Insider Changes in Ownership
- 4 Insider Changes in Ownership
- CORRESP Other Correspondence Between Filers and SEC Staff
- PRER14A Other PRER14A
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
Page 20 of 31 · 616 filings